TEVA GETS FINAL APPROVAL FOR OXYCODONE ER TABLETS

A A

The FDA has granted final approval to Teva Pharmaceutical's oxycodone extended-release tablets in 10-, 20- and 40-mg dosage strengths. Oxycodone ER tablets are the generic equivalent of Purdue Pharma's Oxycontin tablets, a product indicated for the treatment of moderate-to-severe pain when continuous analgesia is needed for an extended period of time.